Tradestie Institutional Equity Comparison Engine

DXCM vs EW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DXCM Overall Edge

DXCM Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DXCM trades at 25.3x Forward P/E with 24.0% operating margin (+11.2% YoY revenue) versus EW at 30.1x Forward P/E and 28.8% operating margin (+10.5% YoY). In options structure, DXCM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against EW sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DXCM
DXCM 25.3x vs EW 30.1x Fwd P/E
Growth & Margin Winner DXCM
Op Margin 24.0% vs 28.8% ยท YoY +11.2% vs +10.5%
Momentum & Technical Winner DXCM
1Y +32.8% vs +18.4% ยท 52W Pos 63% vs 82%
Options & Structure Winner DXCM
CONSOLIDATION (15th %ile IV) vs UNCLASSIFIED (100th %ile IV)
DXCM NASDAQ
DexCom, Inc.
Surgical & Medical Instruments & Apparatus
$79.32
-1.08% 1D
Market Cap $29.9B
1M Return +1.28%
1Y Return +32.8%
Forward P/E 25.3x
Unified AI Score
50.8 / 100 HOLD
Tech 49.0 Fund 56.0 Flow 68.0 Mom 54.0
EW NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$101.85
-1.95% 1D
Market Cap $59.7B
1M Return +13.05%
1Y Return +18.4%
Forward P/E 30.1x
Unified AI Score
40.0 / 100 SELL
Tech 24.0 Fund 43.0 Flow 55.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DXCM +32.8% EW +18.4% Spread: +14.4 pp (DXCM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DXCM Revenue EW Revenue DXCM Op. Margin EW Op. Margin Margin Edge
FY2018 $1.03B $3.72B -18.1% 20.1% EW
FY2019 $1.48B $4.35B 9.6% 26.4% EW
FY2020 $1.93B $4.39B 15.5% 20.5% EW
FY2021 $2.45B $5.23B 10.9% 32.3% EW
FY2022 $2.91B $4.46B 13.4% 33.6% EW
FY2023 $3.62B $5.01B 16.5% 26.1% EW
FY2024 $4.03B $5.44B 14.9% 25.3% EW
FY2025 $4.66B $6.07B 19.6% 20.8% EW

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DXCM (6) vs EW (4)
Institutional Metric DXCM EW Criterion Row Winner
Market Capitalization Scale $29.9B $59.7B Larger Scale EW
Trailing P/E Ratio Valuation 31.6x 60.4x Lower Multiple DXCM
Forward P/E Ratio Valuation 25.3x 30.1x Lower Multiple DXCM
Revenue Growth (YoY) Growth +11.2% +10.5% Higher Growth DXCM
Operating Margin (TTM) Profitability 24.0% 28.8% Higher Margin EW
Net Profit Margin Profitability 19.4% 15.3% Higher Margin DXCM
Return on Equity (ROE) Capital Efficiency 37.7% 9.3% Higher ROE DXCM
52-Week Range Position Momentum 63% ($57โ€“$93) 82% ($75โ€“$108) Stronger Trend EW
Beta / 30D Volatility Risk Regime 0.59ฮฒ ยท 43% Vol 0.43ฮฒ ยท 27% Vol Lower Realized Risk EW
Unified Institutional Score Composite Signal 50.8 / 100 (HOLD) 40.0 / 100 (SELL) Higher Composite DXCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DXCM vs EW Buy Guide
DXCM CONSOLIDATION
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live DXCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DXCM nor EW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.